Torthaí cuardaigh - Nobuhiro Ando
- 1 - 3 toradh as 3 á dtaispeáint
-
1
A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer de réir Kensaku Yoshida, Takuji Iwashita, Shinya Uemura, Akinori Maruta, Mitsuru Okuno, Nobuhiro Ando, Keisuke Iwata, Junji Kawaguchi, Tsuyoshi Mukai, Masahito Shimizu
Foilsithe / Cruthaithe 2017Artigo -
2
Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line FOLFIRINOX Failure de réir Naoki Mita, Takuji Iwashita, Shinya Uemura, Kensaku Yoshida, Yuhei Iwasa, Nobuhiro Ando, Keisuke Iwata, Mitsuru Okuno, Tsuyoshi Mukai, Masahito Shimizu
Foilsithe / Cruthaithe 2019Artigo -
3
Prospective randomized study of endoscopic biliary stone extraction using either a basket or a balloon catheter: the BasketBall study de réir Noritaka Ozawa, Ichiro Yasuda, Shinpei Doi, Takuji Iwashita, Masahito Shimizu, Tsuyoshi Mukai, Masanori Nakashima, Tesshin Ban, Issei Kojima, Koichiro Matsuda, Mitsuru Matsuda, Yusuke Ishida, Yoshinobu Okabe, Nobuhiro Ando, Keisuke Iwata
Foilsithe / Cruthaithe 2016Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Adverse effect
Cancer
Clinical endpoint
Clinical trial
Colorectal cancer
Gastroenterology
Internal medicine
Pancreatic cancer
Surgery
Balloon
Balloon catheter
Bile duct
Catheter
Chemotherapy
Common bile duct
FOLFIRINOX
Febrile neutropenia
Gemcitabine
Hepatology
Irinotecan
Neutropenia
Oncology
Overall survival
Oxaliplatin
Paclitaxel
Pancreatitis
Phases of clinical research
Progression-free survival
Randomized controlled trial